Selank Antiviral Research: Influenza & Interferon-Alpha
A 2009 preclinical study examining Selank's antiviral activity against influenza H3N2 in cell culture and animal models, including interferon-alpha gene expression findings.
A 2009 preclinical study examining Selank's antiviral activity against influenza H3N2 in cell culture and animal models, including interferon-alpha gene expression findings.